U.S. Food and Staples Retail Stock News

NYSE:ATKR
NYSE:ATKRElectrical

Atkore (ATKR) Valuation Check After Sharp Earnings And Profitability Declines

Q1 earnings put Atkore’s recent performance in focus Atkore (ATKR) has come under closer scrutiny after first quarter results showed sales of US$655.55 million versus US$661.6 million a year earlier, with net income at US$15.03 million compared with US$46.34 million. See our latest analysis for Atkore. The weaker first quarter result comes after a period where short-term share price momentum has faded, with a 7-day share price return showing a decline of 4.81% and a 1-year total shareholder...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

What Amneal Pharmaceuticals (AMRX)'s Index Additions and Opioid Settlement Mean For Shareholders

Amneal Pharmaceuticals, Inc. was recently added to the S&P 1000, S&P Composite 1500, S&P 600, and S&P 600 Health Care indices, while also making effective on January 29, 2026, a nationwide opioid settlement that includes US$88.5 million in cash payments and up to US$177.4 million in naloxone nasal spray over ten years. This combination of index inclusions and a broad opioid settlement materially reshapes Amneal’s profile by widening its investor base and reducing legal uncertainty with...
NYSE:SNOW
NYSE:SNOWIT

Snowflake Deepens AI Ambitions With OpenAI Deal And New Sector Tools

Snowflake (NYSE:SNOW) announced a multi-year partnership with OpenAI to bring models such as GPT-5.2 directly into its Cortex AI platform. The collaboration focuses on co-developing enterprise AI tools, including custom AI agents, with built-in governance and security controls. Snowflake also introduced new AI driven products like Cortex Code and Semantic View Autopilot, plus new industry offerings, including Energy Solutions. Snowflake is trading at $175.95, with returns of 8.6% over 3...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Valuation Check As Strong Earnings And Bullish Analyst Outlook Draw Fresh Attention

Globe Life (GL) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with an updated outlook that included higher earnings guidance and an additional analyst update following the release. See our latest analysis for Globe Life. Globe Life’s latest earnings, share repurchases and fresh analyst commentary have arrived after a steady run. The share price closed at US$141.42 with a 1 year total shareholder return of 16.63%, while the 90 day share price return...
NYSE:DAR
NYSE:DARFood

Assessing Darling Ingredients (DAR) Valuation As Earnings Optimism And Analyst Upgrades Drive Recent Rally

Darling Ingredients (DAR) is back in focus this week as investors watch for Wednesday’s after hours earnings report, following last quarter’s revenue beat and stronger than expected adjusted operating income performance. See our latest analysis for Darling Ingredients. At a share price of $48.40, Darling Ingredients has seen a 23.85% 1 month share price return and a 41.07% 3 month share price return. The 1 year total shareholder return of 22.22% contrasts with weaker 3 and 5 year total...
NasdaqGS:LI
NasdaqGS:LIAuto

Is Li Auto’s (LI) January Deliveries Milestone Redefining Its Core EV Growth Narrative?

Li Auto Inc. reported that it delivered 27,668 vehicles in January 2026, bringing its cumulative deliveries to 1.57 million as of January 31, 2026. This milestone underscores how monthly delivery volumes have become a central operational yardstick for assessing Li Auto’s progress in the electric vehicle market. We will now examine how Li Auto’s January delivery performance shapes the company’s investment narrative and future growth considerations for investors. Invest in the nuclear...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

A Look At Qualcomm (QCOM) Valuation As Handset Guidance Softens On Supply And China Demand Headwinds

QUALCOMM (QCOM) is back in focus after first quarter results and fresh guidance pointed to pressure in its core handset business, with memory chip shortages and softer Chinese demand weighing on the near term outlook. See our latest analysis for QUALCOMM. Those handset concerns have fed directly into recent trading, with the share price at US$138.93 after a 1-day share price return of 1.16% but a 30-day share price return decline of 21.85% and a year-to-date share price return decline of...
NasdaqCM:STEX
NasdaqCM:STEXMedical Equipment

Assessing Streamex (STEX) Valuation After Recent Leadership Changes And Shifting Shareholder Returns

Streamex (STEX) is back on investors’ radar after a pair of leadership changes, with co founder Morgan Lekstrom becoming Executive Chairman and NYU finance professor Anthony Marciano joining the board and Audit Committee. See our latest analysis for Streamex. Those boardroom changes arrive after a sharp run, with a very large 1 year total shareholder return contrasting with a 3 year total shareholder return that is still down 78%, and recent share price weakness, including a 90 day share...
NasdaqGS:CYBR
NasdaqGS:CYBRSoftware

A Look At CyberArk Software (CYBR) Valuation As Earnings Highlight Revenue Growth And A Smaller Net Loss

Earnings report puts CyberArk Software (CYBR) in focus CyberArk Software (NasdaqGS:CYBR) is back on investors’ radar after its latest earnings release, which paired higher fourth quarter and full year 2025 revenue with a much smaller quarterly net loss. See our latest analysis for CyberArk Software. The earnings release and upcoming WEST Conference appearance have arrived after a weaker patch for the stock. The 30 day share price return is 10.40% and the 90 day share price return is 20.85%,...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Valuation Check After Revenue Growth And New AI Security Offerings

Gen Digital (GEN) has been busy, combining higher reported revenue and a growing customer base with new AI focused security offerings such as the Gen Agent Trust Hub and Norton Neo, along with dividend and buyback activity. See our latest analysis for Gen Digital. At a share price of $24.60, Gen Digital has seen a 9.58% 7 day share price return after a weaker 30 and 90 day period, while its 3 and 5 year total shareholder returns remain positive, hinting that recent momentum is picking up...
NYSE:VNO
NYSE:VNOOffice REITs

Assessing Vornado Realty Trust (VNO) Valuation After Recent Share Price Weakness

Why Vornado Realty Trust is on investors’ radar today Vornado Realty Trust (VNO) is drawing attention after its recent trading performance, with the stock reflecting mixed short term returns and a value score that may prompt closer scrutiny from income and real estate focused investors. See our latest analysis for Vornado Realty Trust. At a share price of US$30.99, Vornado’s recent 1-day share price return of a 0.90% decline and 30-day share price return of a 10.20% decline contrast with a...
NYSE:LMND
NYSE:LMNDInsurance

Assessing Lemonade (LMND) Valuation As Customer Growth And AI Plans Attract Fresh Investor Attention

Lemonade (LMND) is back in focus after revealing that its customer base nearly tripled between 2020 and the third quarter of 2025, along with plans to expand premiums and refine its AI-driven insurance platform. See our latest analysis for Lemonade. The latest customer growth plans are playing out against a choppy share price backdrop, with a 1-day share price return of a 2% decline and a 7-day share price return of a 12% decline. At the same time, the 1-year total shareholder return of 122%...
NYSE:VMI
NYSE:VMIConstruction

How Investors Are Reacting To Valmont Industries (VMI) Balancing Softer Sales With Precision Agriculture Investment

Valmont Industries recently reported quarterly results showing slightly softer revenue but preserved profitability through cost controls and improved business mix, while continuing to invest in precision agriculture technology and grid reliability solutions. This combination of earnings resilience and commitment to long-term infrastructure and agriculture themes has focused investor attention on how the company is positioning its portfolio. Next, we’ll examine how this emphasis on precision...
NYSE:DT
NYSE:DTSoftware

February 2026's Noteworthy Stocks Estimated Below Intrinsic Value

As February 2026 begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 ending sharply higher, reflecting investor optimism despite ongoing geopolitical and economic uncertainties. In this environment of fluctuating market dynamics and evolving trade agreements, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between market price and intrinsic value.
NYSE:RNG
NYSE:RNGSoftware

Insider Favorites Rumble And Two Other Growth Stocks

As the U.S. stock market begins February on a high note, with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, investors are keenly observing growth companies that exhibit strong insider ownership. In this thriving market environment, stocks with substantial insider stakes can often signal confidence in the company's potential, making them appealing options for those looking to align their investments with insiders who have a vested interest in the...
NasdaqGS:API
NasdaqGS:APISoftware

February 2026's Promising Penny Stocks To Consider

As February 2026 begins, the U.S. stock market has seen a robust start, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. This positive momentum reflects broader economic optimism and renewed investor confidence, despite ongoing geopolitical developments and economic policy shifts. In this context, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential to offer growth opportunities at an...
NasdaqCM:RDVT
NasdaqCM:RDVTSoftware

Discovering 3 Undiscovered Gems in the US Market

As February begins, the U.S. stock market has shown robust performance with major indices like the Dow Jones and S&P 500 experiencing significant gains, reflecting a positive start to the month despite recent economic uncertainties such as government shutdowns and trade negotiations. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential; these undiscovered gems often thrive by capitalizing on niche markets or...
NasdaqCM:OSPN
NasdaqCM:OSPNSoftware

Three Noteworthy Dividend Stocks To Consider

As February begins, U.S. stock markets have surged, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In this dynamic market environment, dividend stocks can offer investors a blend of income stability and potential growth, making them an attractive consideration amidst fluctuating economic conditions.
NYSE:PATH
NYSE:PATHSoftware

A Look At UiPath (PATH) Valuation After Recent Share Price Weakness

With no single fresh headline moving UiPath (PATH) today, the recent share performance stands out, including a 20% decline over the past month and negative total returns over the past year and the past 3 months. See our latest analysis for UiPath. At a share price of $13.00, UiPath’s recent 7 day share price return of 3.67% contrasts with a 30 day share price decline of 20.34% and a 1 year total shareholder return of 8.64% in the red. This points to fading momentum as investors reassess...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside

Revvity (NYSE:RVTY) introduced several new discovery and automation platforms at SLAS2026. The company showcased the Opera Phenix OptIQ high content screening system, EnVision Nexus One plate reader, and AssayMate workstation. Revvity also highlighted collaborations around automated next generation sequencing workflows at the event. Revvity, which focuses on life science tools and diagnostics, is pushing deeper into high throughput drug discovery and lab automation with these SLAS2026...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Fiserv Reset Seeks Cleaner Execution As Lawsuits Test Growth Story

Fiserv (NasdaqGS:FISV) is undergoing a reset under CEO Mike Lyons, centered on the "One Fiserv" plan to unify operations and simplify the business. The company has made leadership and board changes aimed at improving oversight, technology focus, and execution. Fiserv is also facing lawsuits that claim it previously overstated growth metrics, raising questions about past disclosures and investor communications. Fiserv sits at the crossroads of payments, banking technology, and merchant...
NYSE:CMS
NYSE:CMSIntegrated Utilities

How Investors May Respond To CMS Energy (CMS) Dividend Increase Amid Higher 2025 Earnings

In February 2026, CMS Energy’s Board of Directors raised the quarterly common stock dividend to US$0.57 per share from US$0.5425, alongside reporting higher fourth-quarter and full-year 2025 sales, net income, and diluted earnings per share compared with the prior year. The combination of increased earnings and a higher dividend highlights CMS Energy’s emphasis on balancing business investment with ongoing cash returns to shareholders. Next, we’ll examine how CMS Energy’s earnings growth,...
NYSE:MCD
NYSE:MCDHospitality

McDonald's Board Move And Malaysia Expansion Plans Under Investor Scrutiny

McDonald's (NYSE:MCD) has appointed Ford CEO James D. Farley, Jr. to its Board of Directors. McDonald’s Malaysia plans to invest in opening 100 new outlets and upgrading digital platforms over the next five years. For readers tracking large consumer brands, McDonald's sits at the intersection of quick-service dining, global franchising, and increasingly, digital ordering and delivery. The addition of a leader from the auto sector brings experience from another global, operationally complex...
NYSE:MDT
NYSE:MDTMedical Equipment

Does Antitrust Verdict Targeting Hospital Contracts Change The Bull Case For Medtronic (MDT)?

In early February 2026, a California federal jury found Medtronic liable for anticompetitive conduct in the advanced bipolar surgical devices market and ordered the company to pay more than US$381 million in damages to rival Applied Medical under U.S. and California antitrust laws. Beyond the large financial penalty, the verdict targets Medtronic’s contracting practices with hospitals and group purchasing organizations, potentially reshaping how its surgical devices compete for...